L-R pairs, e.g., Lamb1/Cd44, are already known to drive the metastatic capacity of CRC and to support intratumoral CSC function by upregulation of stem cell–supporting pathways (34, 35). The gene discussed is CD44; the disease is colorectal carcinoma.